咪达普利

Imidapril

未知生产厂商

Imidapril is an ACE inhibitor used in the treatment of essential hypertension.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Imidapril is an ACE inhibitor used in the treatment of essential hypertension.

用于治疗原发性高血压、肾实质性病变所致的继发性高血压。

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters
US 7094920 B2申请人: FERMENTA BIOTECH LTD优先权: 2001
US
2 件公开
Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
US 2004048346 A1申请人: TIKARE RAVEENDRA KHANDURAO优先权: 2000
US
Methods for Obtaining a Fast Dissolving Imidapril Powder
US 2008167358 A1申请人: MOREAU MARINETTE优先权: 2005
US
Method for synthesizing heteroaromatic carboxylate and heterocyclic amino acid
CN 101177370 B申请人: UNIV ZHEJIANG TECHNOLOGY优先权: 2007
CN
Medicinal composition containing amlodipine, ACE inhibitor and stains
CN 101642571 A申请人: LIYAN WANG优先权: 2009
CN
一种制备咪达普利关键中间体及其衍生物的方法
CN 105713068 B申请人: 湖南九典制药股份有限公司优先权: 2014
CN
Preparation method of imidapril hydrochloride
CN 106117308 A申请人: JIANGSU YONGAN PHARMACEUTICAL CO LTD优先权: 2016
CN
Imidapril hydrochloride tablet and preparation method thereof
- CN 106137992 A
  申请人: BEIJING BAIAO PHARMACEUTICALS CO LTD优先权: 2016
  CN
- CN 108514552 A
  申请人: TIANJIN TANABE SEIYAKU CO LTD优先权: 2018
  CN
Organic impurities of imidapril hydrochloride and preparation method thereof
CN 111253315 A申请人: BEIJING SUN NOVO PHARMACEUTICAL RES CO LTD优先权: 2020
CN
盐酸咪达普利片剂及其制备方法
CN 111329840 B申请人: 北京阳光诺和药物研究股份有限公司优先权: 2020
CN